|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Clinical Neuro-Oncology |
Hermelin Brain Tumor Center, Departments of Neurosurgery (L.R.R., S.E.R.) and Neurology (L.R.R.), Henry Ford Hospital, Detroit, MI 48202, and Josephine Ford Cancer Center (S.T.), Detroit, MI 48202; USA
1 Address correspondence to Lisa R. Rogers, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202 (lrogers{at}neuro.hfh.edu).
Abstract
We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer.
References
Boogerd, W., Hart, A.A.M., van der Sande, J.J., and Engelsman, E. (1991) Meningeal carcinomatosis in breast cancer: Prognostic factors and influence of treatment. Cancer 67,1685 -1695.[CrossRef][ISI][Medline]
Chamberlain, M.C. (1992) Current concepts in leptomeningeal metastasis. Curr. Opin. Oncol. 4, 533-539.[Medline]
Grossman, S.A., and Krabak, M.J. (1999) Leptomeningeal carcinomatosis. Cancer Treat. Rev. 25,103 -119.[CrossRef][ISI][Medline]
Heier, M.S., Heintz, R., and Fossa, S.D. (1986) Passage of 5'-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study. Acta Neurol. Scand. 74,240 -244.[Medline]
Jaeckle, K.A., Phuphanich, S., van den Bent, M.J., Aiken, R., Batchelor, T., Campbell, T., Fulton, D., Gilbert, M., Heros, D., Rogers, L., O'Day, S.J., Akerley, W., Allen, J., Baidas, S., Gertler, S.Z., Greenberg, H.S., LaFol lette, S., Lesser, G., Mason, W., Recht, L., Wong, E., Chamberlain, M.C., Cohn, A., Glantz, M.J., Gutheil, J.C., Maria, B., Moots, P., New, P., Rus sell, C., Shapiro, W., Swinnen, L., and Howell, S.B. (2001) Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br. J. Cancer 84,157 -163.[CrossRef][Medline]
McEvoy, G.K. (Ed.) (2002) Capecitabine. In: AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, Inc., pp.916 -921.
Siegal T. (1998) Leptomeningeal metastases: Rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy? J. Neuro oncol. 38,151 -157.[CrossRef][Medline]
Wang, M.L., Yung, W.K., Royce, M.E., Schomer, D.F., and Theriault, R.L. (2001) Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. Am. J. Clin. Oncol. 24,421 -424.[CrossRef][ISI][Medline]
This article has been cited by other articles:
|
|
 |
|
  M. C. Chamberlain Neoplastic Meningitis Oncologist, September 1, 2008; 13(9): 967 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 December 13 Highlight and Commentary: Capecitabine-induced multifocal leukoencephalopathy Neurology, December 13, 2005; 65(11): 1685 - 1685. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
